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A B S T R A C T
The mechanisms of neurovascular coupling contribute to ensuring brain energy supply is suﬃcient to meet
demand. Despite signiﬁcant research interest, the mechanisms underlying increases in regional blood ﬂow that
follow heightened neuronal activity are not completely understood. This article presents a systematic review and
analysis of published data reporting the eﬀects of pharmacological or genetic blockade of all hypothesised
signalling pathways of neurovascular coupling. Our primary outcome measure was the percent reduction of the
neurovascular response assessed using in vivo animal models. Selection criteria were met by 50 primary sources
reporting the eﬀects of 79 treatments. Experimental conditions were grouped into categories targeting me-
chanisms mediated by nitric oxide (NO), prostanoids, purines, potassium, amongst others. Blockade of neuronal
NO synthase was found to have the largest eﬀect of inhibiting any individual target, reducing the neurovascular
response by 64% (average of 11 studies). Inhibition of multiple targets in combination with nNOS blockade had
no further eﬀect. This analysis points to the existence of an unknown signalling mechanism accounting for
approximately one third of the neurovascular response.
1. Introduction
Constant and optimal nutrient and oxygen supply as well as eﬀec-
tive removal of metabolic waste products (e.g. CO2) are ensured by
several mechanisms controlling cerebral blood ﬂow. Control of global
cerebral circulation is provided by metabolic factors, cerebral auto-
regulation, and autonomic mechanisms (Willie et al., 2014). Fine-
tuning and continuous adjustment of local cerebral blood ﬂow in accord
with the levels of neuronal activity and metabolism are achieved by
operation of the neurovascular coupling mechanism. The functional
signiﬁcance of this mechanism arises from 1) the inability of the brain
to store signiﬁcant energy reserves; 2) highly dynamic and regionally
heterogeneous metabolism; 3) volume constraints imposed by the cra-
nium; and 4) the need to maximise the eﬃcacy of energy use.
The mechanisms underlying neurovascular coupling have been the
subject of intense research interest for the past ∼25 years for two im-
portant reasons. Firstly, changes in local brain blood ﬂow which follow
changes in neuronal activity provide the physiological basis of blood
oxygen level dependent (BOLD) functional MRI (fMRI) imaging (Buxton
and Frank, 1997). Regional cerebral blood ﬂow changes in humans can,
therefore, be measured non-invasively and used as a surrogate to assess
changes in the neuronal activity (Attwell and Iadecola, 2002).
Secondly, impaired mechanisms controlling brain blood ﬂow may
contribute to cognitive impairment and potentially precipitate the de-
velopment of dementia/ neurodegenerative disease (Iadecola, 2017).
However, despite continued experimental scrutiny by many research
groups, the cellular and molecular mechanisms of the neurovascular
response are not fully understood and/or remain controversial. Here,
using meta-analysis, we evaluated the results of experimental studies
that aimed to identify the signalling mechanism(s) of the neurovascular
coupling response. We analysed the relative eﬃcacy of experimental
treatments targeting all the hypothesised pathways. Our analysis sug-
gests that a substantial proportion of the neurovascular response is
mediated by an as yet unknown mechanism.
2. Metabolic feedback mechanisms
The physiological signiﬁcance of the neurovascular response is
predicated on the fact that neuronal activity requires copious amounts
of energy substrates. Oxygen and glucose are used to generate ATP,
which is required to maintain ion gradients and provide energy to fuel
the mechanisms of neurotransmitter release/recycling that make neu-
ronal communication and brain information processing possible
(Attwell and Laughlin, 2001; Howarth et al., 2012). As levels of
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neuronal activity are believed to be highly heterogeneous across the
brain (which has no signiﬁcant stores of metabolic substrates), blood
ﬂow is redirected to support regions of heightened activity.
Feedback mechanisms are fundamental for the operation of all
physiological systems, including those which maintain energy home-
ostasis. A metabolic feedback hypothesis of brain blood ﬂow regulation
was proposed by Roy and Sherrington (1890) who observed that pro-
ducts of cerebral metabolism released during brain asphyxia (hypoxia/
hypercapnia) dilate cerebral vasculature. These observations led to the
hypothesis that signals increasing local brain blood ﬂow are generated
in response to a reduction in supply of metabolic substrates and/or
accumulation of metabolic waste products (Kety, 1950).
A reduction in the local concentration of oxygen and/or glucose
might, therefore, serve as a suitable negative feedback trigger to initiate
the neurovascular response. Brain metabolism is argued to be sig-
niﬁcantly more sensitive to the decreases of oxygen delivery over that
of glucose (Leithner and Royl, 2014). Indeed, experimental studies in
anesthetised rats involving raising the arterial concentration of glucose
up to ∼18mmol L−1 demonstrated no eﬀect of excess glucose on the
neurovascular response (Wolf et al., 1997).
Earlier studies suggested that neurovascular response might be
triggered by brain tissue hypoxia associated with the increased neu-
ronal activity (Malonek and Grinvald, 1996; Oﬀenhauser et al., 2005;
Thompson et al., 2003). A study conducted in rat brain slices demon-
strated that parenchymal oxygen tension determines the polarity of
cerebrovascular responses that follow activation of perivascular astro-
cytes by intracellular Ca2+ uncaging (Gordon et al., 2008). More re-
cently astrocytes themselves have been shown to be acutely sensitive to
hypoxia (Angelova et al., 2015). Red blood cells have also been pro-
posed to function as oxygen sensors responding with conformational
changes to decreases in brain PO2 during neuronal activation (Wei
et al., 2016). Freeman and Li (2016) reported faithful coupling between
neuronal activity and local tissue PO2 decreases upon visual stimulation
in the anesthetised cat. However, the magnitude of the neuronal ac-
tivity-induced transient brain parenchymal PO2 decreases is small (∼1-
5mmHg) (Freeman and Li, 2016; Parpaleix et al., 2013; Wei et al.,
2016) and neurovascular responses are not aﬀected in conditions of
normobaric (Wolf et al., 1997) or hyperbaric hyperoxia in rats
(Lindauer et al., 2010). In conditions of hyperbaric hyperoxia, en-
hanced neuronal oxygen consumption would be exceeded by the
amount of physically dissolved oxygen. That the neurovascular re-
sponse is unaﬀected under hyperbaric hyperoxia would suggest it is
unlikely to be triggered by (small) associated decreases in local tissue
oxygenation.
Could a build up of metabolic waste products be mediating the
neurovascular response? CO2, protons and lactate have powerful eﬀects
on cerebral vasculature and are generated proportionately with in-
creased brain tissue metabolism.
Astrocytes have been shown to detect local increases in CO2 or
proton concentrations responding to these stimuli with increases in
intracellular [Ca2+] (Gourine et al., 2010; Howarth et al., 2017), which
may lead to the release of vasoactive signalling molecules. Release of
lactate via several parallel mechanisms, involving certain membrane
channels (Karagiannis et al., 2016; Sotelo-Hitschfeld et al., 2015) is
coupled to metabolic signalling pathways (Fernandez-Moncada et al.,
2018) and follows enhanced neuronal activity. Yet, the roles of locally
produced CO2, H+ and lactate as potential triggers of the neurovascular
response have not been experimentally addressed. There is evidence
that brain parenchymal pH does not change or even becomes alkaline
due to neuronal activity-induced increases in ﬂow leading to rapid CO2
washout and activation of the membrane Ca2+-ATPase rapidly re-
moving the excess of extracellular protons (Chen and Chesler, 1992;
Makani and Chesler, 2010; Ueki et al., 1988).
Taken together, these lines of evidence argue against the im-
portance of metabolic feedback mechanisms in triggering changes in
regional cerebral blood ﬂow which follow changes in the neuronal
activity. These mechanisms will not be considered further because of
the insuﬃcient number of relevant studies meeting our inclusion cri-
teria for meta-analysis (described in detail below).
3. Activity-dependent feed-forward mechanisms
An alternative hypothesis to a feed-forward mechanism centres on
the idea that neuronal activity-induced changes in the brain neuro-
chemical milieu mediate neurovascular coupling (Attwell et al., 2010).
According to this hypothesis, neurotransmitter(s) released during sy-
naptic activity and/or extracellular K+ accumulating as a result of
neuronal activity initiate and maintain the neurovascular response
(Longden et al., 2017). Downstream mechanisms have been proposed to
involve recruitment of intermediate cell types, including interneurons
and astrocytes, which signal to vascular smooth muscle cells and peri-
cytes (Mishra et al., 2016). Signiﬁcant experimental evidence suggests
that signalling within the neurovascular unit could be mediated by
several sequential, parallel, competing and/or redundant pathways
involving nitric oxide (NO), prostanoids, purines, amongst others
(Attwell et al., 2010; Iadecola, 2017). Hypothesized signalling path-
ways responsible for the increases in local brain blood ﬂow in response
to enhanced neuronal activity are summarized in Fig. 1.
As newcomers to this ﬁeld we found no up-to-date systematic re-
view of experimental data attempting to analyse the relative sig-
niﬁcance of the proposed signalling pathways. Addressing this need, we
conducted a meta-analysis of publications reporting the results of the
experimental studies targeting all hypothesized pathways of neuro-
vascular coupling either pharmacologically or genetically.
Initial searches returned hundreds of relevant studies published
since the feedforward hypothesis was proposed. In an attempt to distil
critical information, meta-analysis was performed using the selection
criteria outlined next. Our primary outcome measure was the percent
reduction of the cerebrovascular response induced by increased neu-
ronal activity assessed using in vivo animal models. The necessary cri-
teria for inclusion were enhanced neuronal activity, recruited by either
electrical (e.g. forepaw or direct input pathway) or natural (e.g. whisker
deﬂection, visual or motor task) stimulation, evoked the neurovascular
response measured by recording changes in cerebral vessel diameter,
cerebral blood ﬂow, BOLD fMRI or local brain tissue PO2 in experi-
mental animals. While it is accepted that not all of these measures are
exclusively dependent on changes in blood ﬂow only, all have been
used as measures of the neurovascular response. Our secondary mea-
sure was percent reduction of the cerebral vessel response studied in
brain slice preparations in vitro. Studies of neurovascular responses
evoked by application of receptor agonists (e.g. (Busija et al., 2007)),
high K+ (e.g. (Filosa et al., 2006)), direct stimulation of the brain area
from which the response was measured or involving pathological
models (e.g. cortical spreading depression (Ostergaard et al., 2015))
were not included in the analysis. A minimum of two experimental
studies in vivo targeting the same signalling pathway under the above
criteria were required for inclusion. Experimental conditions were
grouped into categories targeting hypothesised signalling pathways
mediated by NO, prostanoids, ATP, adenosine, K+ and those aimed at
blocking several targets. Means were taken from the control and ex-
perimental group data and the eﬀect of a pharmacological agent or
genetic manipulation was expressed as a percentage of the control re-
sponse. The individual data points were then pooled per targeted sig-
nalling pathway and plotted with their respective 95% conﬁdence in-
tervals (Figs. 2 and 3). This analysis standardizes the relative
eﬀectiveness of blocking each target or a combination of targets, al-
lowing direct comparisons. Individual data points are tabulated with
the original source referenced in Supplementary Table 1 for the primary
(in vivo) outcome measure.
A systematic review constrained by these criteria returned 61 re-
ports, from which we analysed the results of 79 experimental conditions
in vivo and 36 experimental conditions in vitro. Upon aggregation,
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blockade of neuronal NOS (nNOS) was found to have the largest eﬀect
of blocking any individual target, reducing the magnitude of the neu-
rovascular response by 64% (average of the results of 11 in vivo studies)
(Fig. 2). Attempts to inhibit multiple targets simultaneously, all of
which included nNOS blockade, resulted in a similar reduction of the
response magnitude (by 61%; average of the results of 6 studies)
(Fig. 2). A potent vasodilator, NO is produced by three NOS isoforms:
endothelial NOS (eNOS), nNOS and inducible NOS (Alderton et al.,
2001). The temporal proﬁle of inducible NOS activation and deactiva-
tion is incompatible with fast control of cerebral blood ﬂow in ac-
cordance with neuronal activity. Both eNOS and nNOS are expressed by
various cellular components of the neurovascular unit. There is evi-
dence that neurovascular response to somatosensory stimulation is re-
duced in eNOS deﬁcient mice (Toth et al., 2015). However, other stu-
dies reported that blockade of all NOS isoforms with Nω-nitro-L-arginine
(L-NNA) attenuated neurovascular response in both the wild type and
eNOS-deﬁcient mice (Ayata et al., 1996) but had no eﬀect in conditions
of nNOS deﬁciency (Ma et al., 1996). Furthermore, the use of non-se-
lective NOS inhibitors was found to have a similar eﬀect on the mag-
nitude of the neurovascular response (reduction by 58%, 14 in vivo
studies; Fig. 2) to that of a pharmacological or genetic nNOS blockade.
It is important to note that NOS blockade is associated with a signiﬁcant
reduction of resting cerebral blood ﬂow (by 28% on average; data re-
trieved from 6 studies that reported baseline changes). Reduction in
basal ﬂow per se would be expected to increase the relative magnitude
of the evoked neurovascular response (as observed, for example, after
caﬀeine administration (Mulderink et al., 2002)). Depending on the
experimental design and particularities of data analysis this may po-
tentially result in overestimation of the neurovascular response in these
conditions. However, Iadecola et al. (1993) applied hypocapnia to in-
duce a comparable reduction in cerebral blood ﬂow as observed fol-
lowing systemic NOS blockade and found no eﬀect of this experimental
Fig. 1. Hypothesized signalling mechanisms of the neurovascular coupling. Schematic illustration of all hypothesized pathways mediating the neurovascular
response suggested by the results of studies summarized in Figures 2 and 3. All pathways are depicted assuming equal weighting. 20-HETE, 20-
Hydroxyeicosatetraenoic acid; A2A, adenosine receptor 2A; AA, arachidonic acid; ACh, acetylcholine; ADO, adenosine; ADP, adenosine diphosphate; AMPAR, α-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor; ATP, adenosine triphosphate; cGMP, cyclic guanosine monophosphate; COX, cyclooxygenase; CYP,
cytochrome P450; DAGL, diacylglycerol lipase; EET, epoxyeicosatrienoic acid; ENT, ectonucleotidase; EP4, prostaglandin E2 receptor 4; EPOX, cytochrome P450
epoxygenase; GABAA, γ-aminobutyric acid (GABA) A receptor; GABAB, γ-aminobutyric acid B receptor; Kxx, potassium channels; mAchR, muscarinic acetylcholine
(ACh) receptor; mGluR5, metabotropic glutamate receptor 5; NMDAR, N-methyl-D-aspartate receptor; NO, nitric oxide; NOS, nitric oxide synthase; P2X1, P2X
purinoceptor 1; P2Y1, P2Y purinoceptor 1; PG, prostaglandin; PLA2, phospholipase A2; PLD2, phospholipase D2.
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manoeuvre on the magnitude of the neurovascular response in an-
esthetised rats.
Thus, NO production by nNOS appears to be critically important for
the development of the neurovascular response. Yet, a signiﬁcant pro-
portion (∼1/3) of the response remains after pharmacological blockade
of nNOS. This assumes complete blockade, which is likely as genetic
nNOS deletion was found to have an eﬀect of similar magnitude as
pharmacological intervention (Yang et al., 2003). Almost complete
enzyme inhibition is possible with pharmacology: for example, Nitro-L-
arginine was reported to inhibit 95 ± 4% of NOS activity when su-
perfused on the cortical surface of anesthetised rats. However, this
treatment was associated with a mere 37 ± 4% inhibition of the
Fig. 2. The eﬀects of blocking hypothesized signalling mechan-
isms of neurovascular coupling in vivo. Summary plot illustrating
the percentage means (with 95% conﬁdence intervals) of neurovas-
cular coupling (NVC) responses that remain in conditions of phar-
macological or genetic blockade of hypothesized signalling pathways
in vivo. Individual data points illustrate the magnitude of the eﬀects of
the 79 experimental treatments reported in the publications refer-
enced. *Multiple category includes the results of experimental studies
that combined neuronal NOS (nNOS) inhibition with blockade of at
least one other target. References: nNOS; (Bonvento et al., 2000;
Burke and Buhrle, 2006; Cholet et al., 1997; Iadecola et al., 1993;
Kitaura et al., 2007; Lindauer et al., 1999; Oﬀenhauser et al., 2005;
Stefanovic et al., 2007; Yang et al., 1999; Yang and Iadecola, 1997;
Yang et al., 2003), Multiple; (Dirnagl et al., 1994; Golanov and Reis,
1994; Leithner et al., 2010; Peng et al., 2004; Petzold et al., 2008;
Tarantini et al., 2015), ATP; (Mishra et al., 2016; Toth et al., 2015;
Wells et al., 2015), NOS; (Adachi et al., 1992; Akgoren et al., 1997;
Dirnagl et al., 1993; Golanov and Reis, 1994; Iadecola et al., 1993; Ido
et al., 2004; Irikura et al., 1994; Kitaura et al., 2007; Ngai et al., 1995;
Peng et al., 2004; Raszkiewicz et al., 1992; Toth et al., 2015; Yang and
Iadecola, 1997; Zhang et al., 1995), Epoxygenase; (Lecrux et al., 2011;
Peng et al., 2002, 2004), Ach; (Arneric et al., 1987; Biesold et al.,
1989; Kocharyan et al., 2008; Zhang et al., 1995), Adenosine; (Dirnagl
et al., 1994; Ko et al., 1990; Meno et al., 2005), COX-2; (Bakalova
et al., 2002; Lecrux et al., 2011; Niwa et al., 2000), AMPA/NMDA;
(Calcinaghi et al., 2011; Lecrux et al., 2011; Petzold et al., 2008; Yang
et al., 1999), COX; (Bakalova et al., 2002; Bruhn et al., 2001; Golanov
and Reis, 1994; St Lawrence et al., 2003), K+ Channels; (Hosford
et al., 2018; Longden et al., 2017, 2011), mGluR; (Calcinaghi et al.,
2011; Lecrux et al., 2011; Petzold et al., 2008; Sloan et al., 2010;
Zonta et al., 2003), GABA; (Kocharyan et al., 2008; Lecrux et al.,
2011), COX-1; (Niwa et al., 2001; Petzold et al., 2008).
Fig. 3. The eﬀects of blocking hypothesized signalling mechan-
isms of neurovascular coupling in vitro. Summary plot illustrating
the percentage means (with 95% conﬁdence intervals) of neurovas-
cular coupling (NVC) responses that remain in conditions of phar-
macological or genetic blockade of hypothesized signalling pathways
in vitro. Individual data points illustrate the magnitude of the eﬀects of
the 36 experimental treatments reported in the publications refer-
enced: K+ Channels; (Filosa et al., 2006; Longden et al., 2014, 2017;
Longden et al., 2011; Zaritsky et al., 2000), COX; (Filosa et al., 2006;
Gordon et al., 2008; Mishra et al., 2016), NOS; (Mapelli et al., 2017;
Mishra et al., 2016; Zonta et al., 2003), ATP; (Mishra et al., 2016),
AMPA/NMDA; (Hall et al., 2014; Mapelli et al., 2017; Mishra et al.,
2016; Zonta et al., 2003), Epoxygenase; (Hall et al., 2014; Mishra
et al., 2016).
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neurovascular response in the area (Zhang et al., 1995). Another study
in anesthetised rats did ﬁnd a positive correlation between the eﬃcacy
of NOS inhibition and the degree reduction of the neurovascular re-
sponse magnitude in the barrel cortex with r2=0.63 (Irikura et al.,
1994). It is important to note that the relative proportion of nNOS ex-
pressing neurones varies between diﬀerent brain areas. In the cerebellar
cortex, where the granular layer has the highest level of nNOS ex-
pression of all brain areas, blockade of the enzyme was found to com-
pletely abolish activity-dependent dilations in slices (Mapelli et al.,
2017). In the rodent cerebral cortex, the proportion of nNOS expressing
neurones is relatively low (0.5–2%), and all these cells are GABAergic
interneurons unevenly distributed between diﬀerent cortical layers
(Valtschanoﬀ et al., 1993). One study conducted in anaesthetized rats,
reported that addition of a NO donor can restore the full magnitude of
the neurovascular response triggered by whisker simulation in condi-
tions of NOS blockade by superfusion of the brain surface with L-NNA
(Lindauer et al., 1999). This suggested that NO might be essential for
other signalling pathway(s) to operate by having something what one
may call a “permissive” role. One report investigated the eﬀect of sys-
temic NOS blockade with L-NMMA on the neurovascular response in 10
human subjects (White et al., 1999). In contrast to the results obtained
in the vast majority of animal studies, NOS blockade had no eﬀect on
neurovascular response when the participants performed a ﬁnger-tap
task.
Several studies targeted another notable hypothesised pathway of
neurovascular coupling which involves the release and vasodilator ef-
fects (on smooth muscle cells and capillary pericytes) of certain pro-
ducts of arachidonic acid metabolism including prostaglandins (PGs)
and epoxyeicosatrienoic acids (EETs). All the enzymes required for the
Ca2+-dependent production of arachidonic acid and PGs from mem-
brane phospholipids are expressed in astrocytes (Mishra et al., 2016),
cells which are often placed at the centre of the neurovascular unit
(Fig. 1). PGs (PGE2 and PGI2 in particular) are potent vasodilators.
Recent evidence has implicated PGE2 as the dominant prostaglandin
mediating neurovascular coupling in the rodent cerebral cortex
(Lacroix et al., 2015). However, there is also evidence obtained in vitro
that PGE2 may, under certain conditions, constrict (rather than dilate)
brain arterioles of rats and mice (Dabertrand et al., 2013). Systematic
review (Fig. 2) has revealed that interfering with this pathway by either
genetic deletion or pharmacological blockade of epoxygenase, inhibi-
tion of cyclooxygenases (COX) with non-speciﬁc agents or blockade of
COX-2 speciﬁcally, results in a 55, 44 or 47% reduction in the magni-
tude of the neurovascular response, respectively. In humans, systemic
non-speciﬁc COX inhibition was also reported to reduce the magnitude
of the BOLD response induced by visual stimulation by 47% (Bruhn
et al., 2001). It is important to note that indomethacin, used in all these
studies as a non-speciﬁc COX inhibitor, is also a potent inhibitor of
cyclic AMP-dependant protein kinase activity (Goueli and Ahmed,
1980), which is integral to any vasomotor response. Therefore, con-
clusions drawn from the results of the experiments using indomethacin
as a COX inhibitor may somewhat overestimate the importance of this
pathway. For example, in humans indomethacin was found to reduce
cerebrovascular CO2 reactivity, while the other non-speciﬁc COX in-
hibitors (naproxen, ketorolac) had no eﬀect on CO2-induced dilations
(Hoiland et al., 2016). On the other hand, the eﬀects of speciﬁc in-
hibition or genetic elimination of COX-2 on neurovascular response
were found to be similar to that of indomethacin, suggesting that oﬀ-
target activity of this drug may not be relevant in this context. Speciﬁc
pharmacological or genetic blockade of COX-1 activity was reported to
reduce the neurovascular response by 24% on aggregate (Fig. 2). Based
on this analysis it would be logical to suggest that the actions of PGs and
EETs mediate the proportion of the neurovascular response which re-
mains after nNOS blockade. However, combined blockade of NOS and
COX or NOS, COX and epoxygenase activity reduces the magnitude of
the neurovascular response on average by 68% (Golanov and Reis,
1994; Leithner et al., 2010; Tarantini et al., 2015). This falls within the
range of the eﬀects observed following inhibition of nNOS activity
alone (Fig. 2).
NO, PGE2 and EETs dilate cerebral blood vessels by their actions on
the arterial smooth muscle cells and/or capillary pericytes, and,
therefore, act as the “eﬀector” molecules of the neurovascular response.
Studies of the mechanisms underlying the initiation of the response fo-
cused on the signalling molecules released by active neurones.
Previously favoured models of the neurovascular coupling mechanism
were centred on synaptic glutamate triggering Ca2+-dependent release
of vasoactive substances by astrocytes (Attwell et al., 2010). However,
this model has been challenged by the evidence showing that mature
astrocytes may not express appropriate glutamate receptors (Sun et al.,
2013; but also see Nizar et al., 2013) and that neuronal activity-induced
changes in ﬂow are not aﬀected in the absence of astroglial IP3 re-
ceptors (Jego et al., 2014; Nizar et al., 2013; Takata et al., 2013). We
proposed in 2015 that (instead of glutamate) the release of purine nu-
cleotide ATP may mediate signalling between neurones and astrocytes
(Wells et al., 2015), a conclusion supported by the results of another
study involving our laboratory (Mishra et al., 2016). Astroglial IP3 re-
ceptors would not be essential for the operation of this mechanism as
ATP may trigger Ca2+ responses in astrocytes via activation of iono-
tropic (P2X) receptors (Mishra et al., 2016). Blockade of ATP actions
(by facilitated enzymatic degradation) or application of purinoceptor
antagonists was found to reduce the magnitude of the neurovascular
response by 57% on average (Fig. 2). Neurovascular response was also
reported to be aﬀected following blockade of other key neuro-
transmitter signalling pathways, including AMPA and NMDA receptors
(inhibition by 44%), metabotropic glutamate receptor 5 (inhibition by
37%), muscarinic acetylcholine receptors (inhibition by 54%) or de-
struction of GABAergic neurones/pharmacological blockade of GABA
receptors (inhibition by 24%) (Fig. 2).
Released ATP is rapidly broken down to adenosine by the activities
of extracellular nucleotidases (Fig. 1). Seven studies targeted adenosine
receptors (some are expressed by vascular smooth muscle cells) and
reported (on average) a 53% reduction in the magnitude of the neu-
rovascular response (Fig. 2). One study involving combined nNOS and
adenosine receptor blockade showed that 42% of the neurovascular
response remains in these conditions (Dirnagl et al., 1994), which is in
the range of the eﬀects elicited by NOS blockade alone (Fig. 2), in-
dicating no additive eﬀect of adenosine receptor inhibition. In contrast,
human studies demonstrated that non-selective adenosine receptor
antagonist caﬀeine increases the magnitude of BOLD response to visual
stimulation by as much as 37%, an eﬀect which was suggested to be due
to a reduction in the baseline ﬂow (Mulderink et al., 2002). It is im-
portant to note that neurones express both the inhibitory (A1) and ex-
citatory (e.g. A2A,2B,3) adenosine receptors, all sensitive to blockade by
caﬀeine, which is also a weak inhibitor of phosphodiesterase activity,
important for the maintenance of vascular tone and reactivity
(Pelligrino and Wang, 1998).
Another potential player which has been proposed to mediate the
neurovascular response is potassium. Original data suggested that
Ca2+-activated K+ (BK) channels on astroglial end-feet release K+
which in turn activates inward-rectifying K+ channels (KIR) expressed
by smooth muscle cells, causing hyperpolarisation and relaxation
(Filosa et al., 2006). However, deletion of BK channels was found to
have no eﬀect on the neurovascular response (Girouard et al., 2010). A
modiﬁed hypothesis suggested that enhanced neuronal activity in-
creases extracellular K+ suﬃciently to trigger smooth muscle relaxation
(Longden et al., 2017). Knock-out of a speciﬁc subunit, KIR2.1, was
found to reduce the neurovascular response by ∼50% (Longden et al.,
2017), while deletion of KIR6.1 had no eﬀect (Hosford et al., 2018). On
aggregate, attempts to interfere with K+-mediated mechanism(s) re-
sulted in 40% inhibition of the neurovascular response (Fig. 2). The
eﬀects of these manipulations in combination with nNOS blockade re-
main to be determined.
While the data obtained using the in vivo preparations are in general
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agreement between the studies (Fig. 2), the results obtained in vitro are
largely inconsistent and represented by the extremes (Fig. 3). For ex-
ample, after NOS or COX inhibition the neurovascular response is either
unaﬀected or completely inhibited (Fig. 3). Accepted major caveats of
the in vitro approach is that the integrity of the neurovascular unit is
compromised and the vessels are not studied at optimal physiological
tension, - the limitation which can be partially addressed by application
of constricting agents (Filosa, 2010). Studies of the vascular responses
using the in vitro preparations also necessitate electrical stimulation to
be applied in a close proximity to the site from which the neurovascular
response is being recorded and could result in a pattern of neuronal
connections and/or network recruitment that may not accurately reﬂect
the activities of physiological neuronal pathways. This highlights the
importance of studying the mechanisms of neurovascular coupling both
in vitro and in conditions of intact synaptic connectivity, normal myo-
genic tone and blood ﬂow. In the opinion of the authors of this analysis,
in vivo animal models remain to be most useful for studies of the neu-
rovascular coupling mechanisms as experiments involving human par-
ticipants are also constrained by limitations imposed by the use of
generally safe pharmacological agents and non-invasive methods of
assessing changes in brain blood ﬂow.
4. Regional segmentation
There is emerging evidence of functional regional segmentation of
the cerebrovascular tree. Using vascular single-cell transcriptomics
Vanlandewijck et al. (2018) demonstrated a clear gradual phenotypic
change (zonation) along the continuum of the arteriovenous network in
the mouse brain. Recent work has also suggested that the signalling
mechanisms responsible for arteriolar vs capillary dilations are distinct
and involve the release and actions of NO and PGE2, respectively
(Mishra et al., 2016). However, the majority of studies included in this
analysis targeted speciﬁc hypothesised signalling mechanisms of neu-
rovascular coupling without taking into the consideration the potential
functional regional segmentation of the cerebral vessels capable of ac-
tive dilation. In the opinion of the authors, the mechanism which
controls the vascular tone at the point of most resistance to ﬂow will
play the key role in shaping the neurovascular response. According to
the recent data reported by Charpak’s group (Rungta et al., 2018) this
point (which the authors called “primary functional unit”) could be
around the ﬁrst branching of the penetrating arteriole, as it dilates ﬁrst
in response to increases in local neuronal activity (in the mouse olfac-
tory bulb).
We also do not discount the possibility that the mechanisms of the
neurovascular response could vary by the brain region. This analysis
included studies of neurovascular coupling in several brain regions,
including olfactory bulb, cerebellum, visual, barrel and somatosensory
cortical regions with the majority of the experiments carried out in the
latter two. Only two studies included in the analysis reported complete
abolition of the neurovascular response in vivo. In anesthetised rats, the
neurovascular responses were blocked in the somatosensory forepaw
region of the cortex after nNOS inhibition (Stefanovic et al., 2007) and
in the visual cortex, also in conditions of non-speciﬁc NOS inhibition
(Ido et al., 2004). There is no in vivo evidence that the neurovascular
response has been eﬀectively blocked in any other brain region. In the
absence of a clear consensus on key cell types and vascular segments
mediating the neurovascular response in diﬀerent brain regions, results
of all the relevant studies were considered together, pooled and ana-
lysed by the targeted signalling pathway.
5. Conclusions
This analysis points to the existence of as yet an unidentiﬁed me-
chanism (or mechanisms) of neurovascular coupling which accounts for
approximately a third of the neurovascular response. There are other
precedents in the history of physiology illustrating the fact that the
signalling mechanisms underlying activity-dependent changes in blood
ﬂow are sometimes diﬃcult to identify. For example, the nature of the
mediator(s) responsible for exercise-induced coronary vasodilation and
increases in coronary blood ﬂow (critically important to support myo-
cardial oxygen demands) remains unclear despite similar research in-
terest and signiﬁcant eﬀort. The involvement of common pathways was
experimentally tested, but prostaglandins and K+ were found to play no
role, while studies involving simultaneous blockade of KATP channels,
NOS, and adenosine receptors demonstrated no eﬀect of the combined
treatment on exercise-induced changes in coronary blood ﬂow
(Goodwill et al., 2017). On the other hand, if functional hyperaemia is
mediated by a single signalling molecule, then the underlying me-
chanism(s) can be rapidly and unequivocally identiﬁed (Burnett et al.,
1992).
Considering the importance of maintaining brain energy balance it
is likely that there are several parallel signalling pathways evolved to
work in concert to shape the neurovascular response and in conditions
when one pathway is blocked experimentally, recruitment of the other
pathway(s) compensates. However, this raises an obvious question of
how the alternative pathways are engaged to maintain (at least par-
tially) the vascular response when the targeted pathway is no longer
functional. Some form of a feedback mechanism which can recruit these
redundant pathway(s) when the need arises would be required.
Alternatively, if the eﬀects of parallel pathways are not simply additive,
then a feedback mechanism may not be needed. It is not inconceivable
that some form of negative synergy limits the eﬀects of one signalling
pathway when it operates in conjunction with the others in the intact
system. Finally, in the opinion of the authors, full understanding of the
complex mechanisms underlying the development and maintenance of
the neurovascular response may emerge if some of the original ideas of
metabolic feedback hypothesis proposed by Roy and Sherrington
(1890) are re-examined using contemporary experimental approaches.
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